Unit of Clinical Epidemiology and Chemotherapy, Vector Control Research Centre, Indian Council of Medical Research (ICMR), Indira Nagar, Pondicherry, India.
Division of Epidemiology and Biostatistics, National Institute of Epidemiology, ICMR, TNHB, Chennai, India.
Lymphat Res Biol. 2020 Dec;18(6):517-525. doi: 10.1089/lrb.2019.0058. Epub 2020 Jun 23.
Mass drug administration and morbidity management and disability prevention (MMDP) though considered as two pillars of global program for elimination of filariasis, implementation of MMDP was disregarded in several endemic countries. Limb hygiene is the main component of MMDP and to address its overall clinical benefits, a community-based study was undertaken in three sets of populations. After obtaining written informed consent, clinical, quality of life (QoL) assessments were carried out and lymphedema volume was measured for three groups of lymphedema patients at intake, at 6, and 12 months follow-up. Filarial lymphedema patients from three sets of villages categorized as "Previous VCRC MMDP," "State MMDP," and "Current VCRC MMDP" were considered for the study. Clinical examination and QoL assessment were carried out independently by a medical officer and a sociologist, respectively. Whoever available at the time of three field visits were registered and included in the study. In total, 67, 63, 66 and 75, 74 and 63 lymphedema (LE) patients completed clinical evaluation and QoL assessment from these groups, respectively. Assessment of repeated measures of clinical parameters at baseline and two time points of follow-up by Friedman's test showed significant clinical improvements in skin color, texture, moisture, and ulcer ( > 0.05), in nails score and intertrigo score ( > 0.01). Assessed by Wilcoxon signed-rank test showed a significant reduction in the frequency Acute Dermato-Lymphangio-Adenitis episodes at 12 months follow-up in all the three MMDP groups ( < 0.001). However, the reduction of LE volume was significant ( = 0.009) only in the current Vector Control Research Centre (VCRC) MMDP group. There was no significant improvement in the QoL in all three groups. To achieve the desired clinical benefits by MMDP home care practices for the filarial lymphedema patients, regular monitoring by the auxiliary health workers is essential. National programs must consider monthly supervision through an integrated approach.
大规模药物治疗和发病管理及残疾预防(MMDP)虽然被认为是全球消灭丝虫病计划的两个支柱,但在几个流行国家,MMDP 的实施被忽视了。肢体卫生是 MMDP 的主要组成部分,为了全面了解其临床益处,在三组人群中进行了一项社区研究。在获得书面知情同意后,对三组淋巴水肿患者进行了临床、生活质量(QoL)评估,并在摄入时、6 个月和 12 个月随访时测量了淋巴水肿体积。来自三个村庄的丝虫性淋巴水肿患者被归类为“以前的 VCRC MMDP”、“州 MMDP”和“当前的 VCRC MMDP”,被认为适合该研究。临床检查和 QoL 评估分别由一名医务人员和一名社会学家独立进行。在三次现场访问时,只要有任何人在,就会进行登记并纳入研究。共有 67、63、66 和 75、74 和 63 名淋巴水肿(LE)患者分别完成了来自这些组的临床评估和 QoL 评估。通过 Friedman 检验对基线和随访两个时间点的临床参数进行重复测量的评估显示,皮肤颜色、质地、水分和溃疡(>0.05)、指甲评分和间擦疹评分(>0.01)有显著的临床改善。通过 Wilcoxon 符号秩检验评估显示,在所有三个 MMDP 组中,在 12 个月随访时急性皮肤淋巴管炎-腺病发作的频率显著减少(<0.001)。然而,只有在当前的 Vector Control Research Centre(VCRC)MMDP 组中,LE 体积的减少才有统计学意义(=0.009)。在所有三组中,QoL 均无显著改善。为了通过 MMDP 家庭护理实践为丝虫性淋巴水肿患者获得所需的临床益处,辅助卫生工作者的定期监测至关重要。国家计划必须考虑通过综合方法进行每月监督。